Common Russian-Inspired Protocols for Combined Use

No single “official” 20-day protocol is universally standardized, as much of the data comes from clinical observations, animal studies, and practitioner adaptations rather than large randomized trials. Protocols vary slightly between sources, but a frequently referenced combined approach for synergy (telomere/aging support from Epithalon + immune restoration from Thymalin) is:

• Daily dosing: 5 mg Epithalon + 5 mg Thymalin (or sometimes 10 mg of each), administered once daily.
• Duration: 20 consecutive days.
• Total per cycle: ~100 mg Epithalon and ~100 mg Thymalin.
• Frequency: Repeat 1–2 times per year, with at least 4–6 months between cycles to avoid diminishing returns.

This 20-day variant aligns with some practitioner recommendations (e.g., from peptide educators referencing Russian research) and extends the more common 10-day course used in Khavinson-related studies, where patients often received 10 mg of each peptide daily (or every other day) for 10 days annually.

Alternative Variations

• Standard “Russian Protocol” for Epithalon alone (often adapted for combo): 10 mg daily for 10 days (total 100 mg), 1–2×/year. Some extend to 20 days at 5 mg/day to reach the same total.
• Lower-dose conservative option: 5 mg Epithalon daily (with or without Thymalin) for 10–20 days.
• Thymalin standalone reference (from Russian labeling/instructions): 5–20 mg IM daily or every other day, with courses of 3–10 days (total 30–100 mg), repeatable after 1–6 months as needed for immune support.

In combined longevity contexts, the 5 mg each × 20 days approach is cited for balanced effects without excessive dosing.

Administration

• Route: Subcutaneous (SubQ) injection is most common in modern adaptations (e.g., into abdominal fat or thigh). Original Russian studies often used intramuscular (IM) injection.
• Timing: Evening/bedtime is frequently preferred for Epithalon due to its links to melatonin and circadian regulation. Thymalin can be given at the same time.
• Reconstitution: Peptides are typically supplied as lyophilized powder in vials. Reconstitute with bacteriostatic water (e.g., 1–2 ml per vial). Calculate units based on concentration (e.g., for a 10 mg vial reconstituted with 1 ml, 5 mg = 0.5 ml / 50 units on an insulin syringe).
• Storage: Refrigerate reconstituted solution; keep powder frozen or cool until use.

Important notes on sourcing and use: These are often handled as research chemicals in many countries (not FDA-approved for human use in the US). In Russia and some CIS countries, related forms like Epithalamin and Thymalin have been used clinically. Always source from reputable suppliers if pursuing research use, and consult a qualified healthcare provider for personalized advice, monitoring (e.g., bloodwork for immune/inflammatory markers), and to rule out contraindications.

Safety and Considerations

• Reported side effects: Generally well-tolerated in studies with no major adverse events noted at these doses. Potential mild injection-site reactions.
• Synergy rationale: The combination has been linked in observational data to greater mortality reduction (up to 4.1-fold in one long-term elderly cohort with annual 10-day courses) compared to either alone.
• Not medical advice: Protocols are derived from research literature and practitioner summaries. Individual responses vary based on age, health status, and goals. Professional medical supervision is essential, especially for injections, lab monitoring, and to avoid interactions.

For the most precise application, refer to primary Khavinson publications or consult a clinician experienced in peptide bioregulators. If you have specific goals (e.g., immune support vs. longevity), more details could help refine this further.